chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Viral UTI symptoms; runny nose; myalgias; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (Viral UTI symptoms), RHINORRHOEA (runny nose) and MYALGIA (myalgias) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (Viral UTI symptoms), RHINORRHOEA (runny nose) and MYALGIA (myalgias). At the time of the report, URINARY TRACT INFECTION (Viral UTI symptoms), RHINORRHOEA (runny nose) and MYALGIA (myalgias) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product information is provided  No treatment product information is provided
Initial and follow up information has been received from a physician and an LPN concerning a 66 year old female patient who on 27-NOV-2006 was vaccinated in the right arm with a dose of Pneumovax 23, lot #651437/0899F.  A dose of Zostavax (MSD), lot #652966/0623F, was administered at the same time in the left arm.  The patient also received a dose of FLUZONE at the same office visit.  On 27-NOV-2006, within 24 hours, the patient developed a fever of 103 degrees.  It was also noted that on 27-NOV-2006 the patient developed redness ("developed over 48 hours"); and severe swelling in the right arm.  The patient said she received Zostavax (MSD) in the right arm, however the physician stated that Pneumovax 23 was given in the right arm and Zostavax (MSD) was given in the left.  The physician reported that her right arm had redness and swelling and spread to arm pit, measuring 8" by 3".  She was treated with BENADRYL and TYLENOL, and DARVOCET was given for pain.  The nurse stated that the patient called the office to say that she had developed shingles in the arm in which she was vaccinated with Pneumovax 23 (Zostavax (MSD) was given in a different arm).  The patient refused to come into the office so that the physician could evaluate or confirm what the patient was saying.  As of 01-DEC-2006, the patient was recovering; all symptoms were much improved.  Additional follow up information has been received concerning the female with a history of fever after flu vaccination approximately 10 years ago who on 27-NOV-2006 was given her first dose of Pneumovax 23, lot #651437/0899F in her right arm; and her first dose of Zostavax (MSD), lot #652966/0623F in her left arm.  Several hours after the injection the patient reported right arm redness and swelling 8" X 3"; and chills and subjective fever on 30-NOV-2006.  An office visit was recommended but the patient declined.  Treatment included ice-packs.  On 19-JAN-2007 the patient received MEDRO DOSEPAK and VICODIN for "resultant myalgia in the arms".  A neurology consult was recommended on 19-JAN-2007 but the patient has not seen a neurologist.  Additional information is not expected.
Received Moderna COvid shot #1 01-12-2021, Lot # 039K20A. Began experiencing breathing problems on 01-17-2021. On 01-18-2021, had to be hospitalized with fever of 103 and heart rate of 160. Diagnosed with bilateral pneumonia and an unidentified virus, tested Covid negative.
Received 1st dose of Jyennos vaccine at 0925 8/23/2022. Around 1030 stated feeling "disconnected/ out of it" and shortly after around 11-1130 began experiencing the sensation of throat swelling/tightness and difficultly swallowing.  Sought care at ER at 1200 and was tx'd with IV dephenhydramine, IV methylprednisolone and IV pepcid. Discharged within a few hours with a Medrol dosepak and OTC antihistamine. Full recovery.
10/16 Pain in R forehead.  10/25 shingles vesicles appeared
2nd night i woke up in the middle of the night felt like needles were coming out of my finger tips in my left hand. I woke up the next morning with a red finger or two and gout got started and today it is much worse.  it is very painful I have had Gout before my 1st vaccine so i know what it is.
Janssen COVID-19 Vaccine EUA  6 Hours after injection I became violently ill. Severe Sweats Severe Vomiting Severe Headache Severe Dizziness (could not stand with out falling) Severe Diarrhea
Patients received vaccine from vials that where in a freezer thought to have gone a temperature excursion; Patients received vaccine from vials that where in a freezer thought to have gone a temperature excursion; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received vaccine from vials that where in a freezer thought to have gone a temperature excursion) and EXPIRED PRODUCT ADMINISTERED (Patients received vaccine from vials that where in a freezer thought to have gone a temperature excursion) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Aug-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received vaccine from vials that where in a freezer thought to have gone a temperature excursion) and EXPIRED PRODUCT ADMINISTERED (Patients received vaccine from vials that where in a freezer thought to have gone a temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received vaccine from vials that where in a freezer thought to have gone a temperature excursion) and EXPIRED PRODUCT ADMINISTERED (Patients received vaccine from vials that where in a freezer thought to have gone a temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product information was provided.  Treatment information was not provided.  Additional information reported include that the data logger was faulty and not the freezer, so there is no actual excursion took place and the freezer had remained within range the whole time.
Tinnitus which I already had but was manageable became much more pronounced in both ears. Very disabling amd upsetting. Dr. prescribed some steroids which seem to help, but then I had to take my second vaccine. And I have the same result
?Covid arm? (raised red rash at injection site) size of half dollar, sore, itchy.  Swollen lymph node by collar bone
Moderna covid 19 vaccine. 0.5ml given instead of 0.25ml.
Shot was given at 2:00pm.  At 4:00pm noticed pain in right side of neck (lymph gland)-fever, chills, muscle & organ pain resulted after a bath at 8:00pm.  Took Motrin at 9:00 and had horrible symptoms until next morning.  Took Motrin again around 5:00am and then better.
26hr p/vax pt states both arms became limp & upper torso felt like it was going into shock;then severe diffused occurred in back;episode lasted 2-3min;saw MD on 24DEC & p/EKG, etc said felt it was d/t vax but told to get dose #2;n, diarrhea
Tender red lump on the lower arm, not around the injection site. Onset a little after injection was given. Came back the next day with tender lump.
Subsequent to receiving three doses of Engerix B, the pt was found to be a non-responder.  As of 08/09/2000, the outcome of the event is unknown.
Seven days post vax, the pt developed a rash (hives). A copy of this report has been forwarded to Aventis Pasteur, manufacturer of IPV.
ear pain in both ears; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (ear pain in both ears) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EAR PAIN (ear pain in both ears). At the time of the report, EAR PAIN (ear pain in both ears) outcome was unknown.            No concomitant medications were reported. No treatment details were reported.
extreme fatigue; sharp pains; extremely painful muscles; extremely painful joints; nausea; slight fever; injection site red; second injection site  broken out in spots/rash; This is a spontaneous report from a contactable consumer.   A non-pregnant 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in left arm on 02Apr2021 19:30 (Batch/Lot Number: ER8730) as dose 2, single (at the age of 40 years old) for COVID-19 immunisation.  Medical history included asthma, endometriosis, hypothyroidism, PCOS, latex allergy, shellfish allergy, seasonal allergy and cats allergy. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 12Mar2021 07:30 (Batch/Lot Number: EN6206) for COVID-19 immunisation and experienced fatigue, nausea, flu-like chills/aches - lasted 3 days, injection site still red 3 weeks later. The patient experienced extreme fatigue, sharp pains, extremely painful muscles and joints, nausea, slight fever - lasted two and a half days, (I slept a full 24 hours on day three), second injection site red and broken out in spots/rash on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Nausea, high fever, chills, brain fog, and disorientation all day for 2 days after being vaccinated. These symptoms continued thru 9/18/2021 AND 9/19/2021. Nausea, brain fog, dizziness and vertigo on 9/20/2021. Felt better on 9/21/2021.
My arm to be tight 11 days after the 1st dose; My arm to be tender; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (My arm to be tight 11 days after the 1st dose) and VACCINATION SITE PAIN (My arm to be tender) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (My arm to be tight 11 days after the 1st dose) and VACCINATION SITE PAIN (My arm to be tender). At the time of the report, LIMB DISCOMFORT (My arm to be tight 11 days after the 1st dose) and VACCINATION SITE PAIN (My arm to be tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  The patient reported that their arm to be tender and tight 11 days post receiving their first dose.  No Concomitant product use was reported. No treatment information was provided
I received the latest COVID vaccine (Pfizer) at a Family Medicine clinic. Within 5 minutes of receiving the vaccine, I experienced an allergic reaction. My ear drums were tight, I had significant heart palpitations, the palms of my hands became very sweaty and I had major tremors. I have had 3 previous COVID vaccinations, all Pfizer, with no reaction. I doubt this was reported as the nurse practitioner said it might be anxiety. It was not anxiety, it was a reaction to the vaccine. The symptoms were exactly what occurs when I eat food that contains MSG. My O2 was normal but my blood pressure kept going up. I was given 50mg orally of Benadryl and the symptoms subsided within 30-45 min.
Presented with abd pain; dx Type 2 NSTEMI due to demand iscemia from Covid 19 infection; Labs: D dimer 1.27; CRP 0.45, Ferritin 121; Tx: Vit D3, Decadron, lovenox, singulair, zinc; O2 remained on room air
Headache, Myalgia, & NauseaVomiting Narrative: got Moderna booster on Friday. On Saturday I had headache, myalgia, nausea, tachycardia, fatigue as well as redness of the injection site. On Sunday nausea persists; redness increased at the injection site with swelling. Also left axillary pain and mild swelling started on Sunday. As of Monday, persistent nausea, redness of the injection site with increased axillary pain ; can hardly use my arm.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On 30-OCT-2013, the patient received ZOSTAVAX, (lot# and route unknown) as recommended for the prevention of shingles. As a direct result of the vaccine, the patient suffered from a shingles outbreak, in addition to chronic pain, rash and lesions to various parts of her body. The patient did not have a shingles outbreak until 11-JUL- 2015. As a direct result of the vaccine, the patient suffered mental and emotional distress due to resulting physical limitations and seriousness of this condition. The patient sustained severe and permanent personal injuries. Further, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The patient incurred medical expenses and other economic harm as a direct result of use of ZOSTAVAX. Herpes zoster was reported to be disabling. Additional information has been requested.
dose administered to patient after more than 1 temperature excursion; dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Apr-2021 at 2:11 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 03-Apr-2021 at 2:11 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 54.76.  No concomitant medications were reported.  Batch number 030B21A administered on 03-Apr-2021 underwent temperature excursion with temperature range of 34 degrees Fahrenheit at 09:00 AM. This vial was moved to fridge on 30-Mar-2021 and beyond use date for the vial was reported as 29-Apr-2021. Product moved to clinic on 03-Apr-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour.  No treatment medications were reported.  This case was linked to MOD-2022-566976 (Patient Link).
5 weeks post second dose of vaccine, muscle jerking/twitching of the arms, legs, neck, and torso began and were persistent daily. Headaches also began at this time. In August 2022, 25mg of Topamax was started. Within 48 hours, symptoms decreased.
virus infection; guess it still within in my body like it still little contagious; Hand, foot and mouth disease; This is a spontaneous report from a contactable consumer. A patient with an unknown age and gender received first dose of BNT162B2 (Pfizer covid-19 vaccine, formulation: solution for injection, batch/lot number: unknown) via unknown route of administration on an unspecified date in Aug2021 as a DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Aug2021, the patient experienced Hand, foot and mouth disease, virus infection; guess it still within in my body like it still little contagious. The patient had first shot 2 weeks ago and due for second shot and about also 2 weeks ago, as patient had a virus infection and over it now, but the patient guess it was still within body like it still little contagious and had a Hand, foot, mouth disease. The patient was wondering if it was ok you can check. The patient had hand foot and mouth disease, so it was wondering was it for me to get the second shot now even though they say it was still contagious. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Fever 7 days, post vax; rash on hand, trunk and face, 10 days, post vax.
Swollen lymph node; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE LYMPHADENOPATHY (Swollen lymph node) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE LYMPHADENOPATHY (Swollen lymph node). At the time of the report, VACCINATION SITE LYMPHADENOPATHY (Swollen lymph node) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment details not provided.
drug ineffective; positive for COVID-19; congested nose; body aches; sore throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old patient received BNT162b2 (COMIRNATY), on 01Mar2022 as dose 1, single (Lot number: EL3247), on 22Mar2021 as dose 2, single (Lot number: EL3247, Expiration Date: May2021) and on 29Sep2021 as dose 3 (booster), single (Lot number: FE3592) at the age of 49 years for covid-19 immunisation. The patient's relevant medical history included: "seasonal allergies" (unspecified if ongoing). Concomitant medication(s) included: MELOXICAM taken for seasonal allergy; TYLENOL taken for seasonal allergy; CLARITIN [LORATADINE] taken for seasonal allergy; NASACORT taken for seasonal allergy.  The following information was reported: PAIN (non-serious) with onset 14Apr2022, outcome "unknown", described as "body aches"; NASAL CONGESTION (non-serious) with onset 14Apr2022, outcome "unknown", described as "congested nose"; OROPHARYNGEAL PAIN (non-serious) with onset 14Apr2022, outcome "unknown", described as "sore throat"; DRUG INEFFECTIVE (medically significant), outcome "unknown"; COVID-19 (medically significant), outcome "unknown", described as "positive for COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive.  Additional information: Patient reported that I tested myself using the At Home test and was positive for COVID-19.  Follow-up attempts are completed. No further information is expected.
Woke up with a mild sore throat.  Next day it was a raging sore throat, with fatigue and body aches.  Did not have a fever.  3/2 went to Urgent care.  Tested positive for COVID-19 on a rapid test.  Tested for Strep Throat, negative.  Doctor proscribed Paxlovid.  Symptoms improved after 3 days, did not notice any effect of Paxlovid for the first couple of days.  Symptoms disappeared after 5 days.  Rebound of symptoms on day 8.  Rebound symptoms were much milder, Sore throat, head and chest congestion.  These symptoms lasted another 5 days, but cough, fatigue and a little bit of a head cold linger to time of reporting.
Felt ill and fainted the day after the vaccine.  Had persistent headaches and went to the ER on 3/27/21.  Feeling better now.  Reported to me, her PCP on 4/13/21.
Hospitalized (10.18.21 - 10.23.21);  COVID-19 positive (10.16.21);  fully vaccinated plus booster Discharge Provider: DO  Primary Care Provider at Discharge: MD Admission Date: 10/18/2021 Discharge Date: 10/23/2021 Discharge disposition: Home Condition on discharge: Stable.  DETAILS OF HOSPITAL STAY:  Respiratory failure [J96.90] COVID-19 [U07.1] HOSPITAL COURSE: Acute hypoxic respiratory failure. Improving  COVID-19 pneumonia. Improving  - Weaned down to 1L by NC.  - Continue course of Decadron/Remdesivir.    D dimer now improving. CTA chest did not show PE  HISTORY OF PRESENT ILLNESS: 73 yo woman with a history of CAD s/p CABG, DM type II poorly controlled, presenting with a week of worsening respiratory symptoms, cough, and body aches. She was seen in the ED on 10/15 and diagnosed with COVID-19. She has had progressive shortness of breath with exertion and did a tele medicine conference with her PCP today. Given exertional hypoxia and worsening symptoms, she was directed to the ED. She also admits to poor oral intake over the time period and generalized weakness. Nothing is helping her symptoms. Any kind of activity makes them worse.  In the ED, labs mostly unremarkable, mild transaminitis, normal WBC count, CXR image personally reviewed with bilateral infiltrates. EKG image reviewed with some lateral T wave flattening, no significant ischemic changes
Report 20010058221 described itching and rash in a 41 year old male who received hep B vaccine recombinant (Engerix-B) for the prophylaxis of hep B. The vaccinee lived with a hep B carrier. Reportedly, the vaccinee had no known drug allergies or medical history. Concomitant medication: Gamma globulin. On 01/19/2001, the vaccinee received his first "adult" left deltoid dose of Engerix-B and a dose of gamma globulin without adverse event. On 02/19/2001, the vaccinee received his second "adult" left deltoid dose of Engerix-B. Post vaccination, in the evening of 02/19/2001, the vaccinee experienced itching and a full body rash. The adverse events resolved without treatment. As of 02/27/2001, the outcome of the events is resolved.
Patient received both vaccines on 12-17-12. Returned to office today 12-19-12 with pain, redness and streaking to right deltoid. Pt was given BENADRYL prescription and told to follow up if no better.